Novo Nordisk is one of the largest pharmaceutical companies in the world. With its release of Ozempic/Wegovy, breakthrough weight loss and diabetes medicines, their surge in earnings has contributed to all of Denmark's GDP growth in the last 6 months! It has also generated a lot of hype and caused the share price to surge. In this episode I do a review of the company and assess its intrinsic fair value through a DCF analysis. Is NVO a good buy at the current price??
Financials from Q4 (December) 2023.
⬤ [ Ссылка ]
🎥Related Videos🎥
How to Find the Intrinsic Value of a Stock: [ Ссылка ]
Google Stock Valuation with DCF: [ Ссылка ]
★☆★ Subscribe: ★☆★
[ Ссылка ]
Follow me on Twitter: @CailonCapital
►[ Ссылка ]
🟠Support Me on Patreon🟠
►patreon.com/CarilonCapitalResearch
Start trading on Interactive Brokers with my link and get free stocks!
►[ Ссылка ]
Best luck investing and God bless!
#valueinvesting #stockmarket #discountedcashflow #NVO #novonordisk #stockanalysis
![](https://i.ytimg.com/vi/_0GmuaAskuQ/maxresdefault.jpg)